Maha Hussain, MD

Maha Hussain, MDCancer.Net Associate Editor: Genitourinary (GU) Cancers
University of Michigan Comprehensive Cancer Center

Dr. Hussain is the Cis Maisel Professor of Oncology, Professor of Medicine and Urology, Associate Director for Clinical Research and Co-leader of the Prostate Cancer Program at the University of Michigan Comprehensive Cancer Center.  Dr. Hussain is an internationally renowned clinical researcher and expert in prostate and bladder cancers. Her research is focused on the development of novel therapeutics integrating scientific advances into clinical trials.

Dr. Hussain serves or has served in a variety of national scientific leadership capacities. She has served as the co-chair for the Prostate Cancer sub-committee of SWOG GU committee.   She is a member of the FY13 Integration Panel (IP) of U.S. Army Medical Research and Materiel Command Prostate Cancer Research Program and the IP’s 2013 Chair.  She has served as a member of the National Cancer Institute (NCI)-Cancer Biomarker Study Section and the NCI’s Prostate cancer task force.  Dr. Hussain is an U.S. Food & Drug Administration (FDA) consultant and has served as a member and the Chair for the FDA Oncology Drug Advisory Committee (ODAC), chair of the ASCO Education Committee, Chair for 2011 ASCO Genitourinary Cancer Symposium Program Committee, and the chair for the 2014 ASCO-GU Symposium Steering Committee in addition to other institutional, regional and national service and leadership roles.

The author of more than 205 scholarly articles and book chapters Dr. Hussain serves or has served on the editorial boards for several national and international specialty publications.  She is the recipient of several honors and awards including the ASCO Statesman Award, the University of Michigan Medical School “League of Research Excellence", and the 2012 “Clinical & Health Services Research award”.  She has been invited to give hundreds of lectures on her work in the United States and many countries around the world and for several years, she has been named as one of the “Best Doctors” in America and America’s Top Doctors for Cancer.

Disclosure: In the past two years, Dr. Hussain has served as a consultant/advisor to Paradigm, Exelixis, and Johnson & Johnson.